Skip to content

Clinical trials

Completed Phase 4 Memory Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Memory Disorders Phase: Phase 4 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20083
20101
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.1
Enzymotec1
Ipsen1
Johns Hopkins University1
NYU Langone Health1
Neurognostics1
Novartis1
Tel-Aviv Sourasky Medical Center1
University of Texas Southwestern Medical Center1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Memory Disorders10
Alzheimer Disease2
Cognitive Dysfunction1
Delirium1
Dementia1
Emergence Delirium1
Multiple Sclerosis1
Multiple Sclerosis, Relapsing-Remitting1
Postoperative Cognitive Complications1
Psychoses, Substance-Induced1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.